Page results
-
Today, 11 February, marks the tenth anniversary of the International Day of Women and Girls in Science, which seeks to bring gender equality in science and promote role models to inspire girls and women into scientific professions.
-
UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.
-
Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.
-
Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the wellbeing of doctors.
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
-
Johanna Moss was appointed to the Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.
-
Carlito Adan - Deputy Lead Nurse Clinical Research Facility
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
File results
-
FOI/2024/0740 - A&E tooth decay admissions for 2021/22, 2022/23 and 2023/24
-
FOI/2024/0741 - HR, finance and payroll contracts/ software updates/ staff contact details
-
FOI/2024/0750 - Spend on law firms for services related to maternity and neonatal care 2021-2023
-
FOI/2024/0776 - Buildings used by the Trust which still contain asbestos
-
FOI/2024/0814 - Asbestos Compensation 2021/22 - 2023/24
-
FOI/2024/0981 - Asbestos Containing Materials (ACMs)/ asbestos register/ asbestos management
-
UCLH board register of interests
-
UCLH Audit Committee terms of reference
-
-